MedPage Today on MSN2d
Better Response, Survival in Head and Neck Cancer With Dual Pre-Op ImmunotherapyTwo neoadjuvant immunotherapy combinations for head and neck cancer substantially increased the response rate versus a single ...
Journal of the American Medical Association study provides further evidence that Multikine can treat unmet need in ~70% of ...
CEL-SCI (CVM) announced that a third-party study published on March 6 in JAMA Oncology provided data that support Multikine’s use as a ...
Researchers from the University of Chicago Medicine Comprehensive Cancer Center have demonstrated the potential of a novel ...
The study enrolled 64 patients with treatment-naïve metastatic melanoma between March 2017 and July 2019. Participants ...
News-Medical.Net on MSN7d
Combination immunotherapy improves treatment response for head and neck cancerResearchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs) found that patients responded better to a combination of two ...
During a live event, Thach-Giao Truong, MD, moderated a discussion on treating a 78-year-old patient with metastatic melanoma ...
A recent study published in JAMA Oncology presents promising new data on a treatment regimen beneficial to patients with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback